SCHEMBL25845119

SCHEMBL25845119

Cc1cccc(C(C)(C)C(=O)O)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
KIF11 P52732 1/20 0.41
KAT6A Q92794 1/20 0.37
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
HTT P42858 2/20 0.34
KDM4C Q9H3R0 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MYC P01106 1/20 0.33
APP P05067 1/20 0.33
CA2 P00918 1/20 0.33
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1626611 0.84 NOTUM (0.40) KAT6AALDH1A1PDK1PDK2PDK3
SCHEMBL1626654 0.83 CES2 (0.44) HPGDAPPCA2
SCHEMBL30501842 0.83 CES2 (0.44) HPGDAPPCA2
SCHEMBL1624964 0.81 ALDH1A1 (0.41) GABRA1GABRB2ALDH1A1KMT2AAPP
SCHEMBL25845024 0.81 PLCG1 (0.46) GABRA1GABRB2KIF11KAT6AALDH1A1
SCHEMBL3633862 0.80 GABRA1 (0.42) GABRA1GABRB2HPGDKDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL28842318 0.79 TRPA1 (0.43) GABRA1GABRB2HPGDKDM4EALDH1A1
Phosphine SCHEMBL29240846 0.79 TRPA1 (0.43) GABRA1GABRB2HPGDKDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL28714249 0.79 GABRA1 (0.41) GABRA1GABRB2HPGDKDM4EALDH1A1
SCHEMBL9626868 0.76 GABRA1 (0.56) GABRA1GABRB2KIF11KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023117681-A1 HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-06-29 WO disclosed